Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Ab...

Por Smolen, Josef S., Wollenhaupt, Jürgen, Gomez-Reino, Juan J., Grassi, Walter, Gaillez, Corine, Poncet, Coralie, Le Bars, Manuela, Westhovens, Rene
Publicado no Arthritis Res Ther (2015)

Baseline autoantibodies preferentially impact abatacept efficacy in patients with rheumatoid arthritis who are biologic naïve: 6-month results from a real-world, international, pro...

Por Alten, Rieke, Nüßlein, Hubert G, Mariette, Xavier, Galeazzi, Mauro, Lorenz, Hanns-Martin, Cantagrel, Alain, Chartier, Melanie, Poncet, Coralie, Rauch, Christiane, Le Bars, Manuela
Publicado no RMD Open (2017)

Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study

Por Schiff, Michael, Keiserman, Mauro, Codding, Christine, Songcharoen, Suthin, Berman, Alberto, Nayiager, Sauithree, Saldate, Cristina, Aranda, Richard, Becker, Jean-Claude, Nys, Marleen, le Bars, Manuela, Reed, Diane Moniz, Poncet, Coralie, Dougados, Maxime
Publicado em 2011

Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised...

Por Conaghan, Philip G, Durez, Patrick, Alten, Rieke E, Burmester, Gerd-Rüdiger, Tak, Paul P, Klareskog, Lars, Catrina, Anca Irinel, DiCarlo, Julie, Gaillez, Corine, Le Bars, Manuela, Zhou, Xianhuang, Peterfy, Charles
Publicado em 2013

Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE study

Por D'Agostino, Maria-Antonietta, Boers, Maarten, Wakefield, Richard J, Berner Hammer, Hilde, Vittecoq, Olivier, Filippou, Georgios, Balint, Peter, Möller, Ingrid, Iagnocco, Annamaria, Naredo, Esperanza, Østergaard, Mikkel, Gaillez, Corine, Le Bars, Manuela
Publicado no RMD Open (2016)

Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

Por Nüßlein, Hubert G., Alten, Rieke, Galeazzi, Mauro, Lorenz, Hanns-Martin, Nurmohamed, Michael T., Bensen, William G., Burmester, Gerd R., Peter, Hans-Hartmut, Pavelka, Karel, Chartier, Melanie, Poncet, Coralie, Rauch, Christiane, Le Bars, Manuela
Publicado no BMC Musculoskelet Disord (2015)

Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study

Por Alten, Rieke, Nüßlein, Hubert, Galeazzi, Mauro, Lorenz, Hanns-Martin, Nurmohamed, Michael T, Bensen, William G, Burmester, Gerd R, Peter, Hans-Hartmut, Pavelka, Karel, Chartier, Mélanie, Poncet, Coralie, Rauch, Christiane, Elbez, Yedid, Le Bars, Manuela
Publicado no RMD Open (2016)

Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE stud...

Por D'Agostino, Maria-Antonietta, Wakefield, Richard J, Berner-Hammer, Hilde, Vittecoq, Olivier, Filippou, Georgios, Balint, Peter, Möller, Ingrid, Iagnocco, Annamaria, Naredo, Esperanza, Østergaard, Mikkel, Boers, Maarten, Gaillez, Corine, Van Holder, Karina, Le Bars, Manuela
Publicado no Ann Rheum Dis (2016)